Elesclomol: A study on copper induced melanoma treatment

Elesclomol is a novel anti-cancer drug that triggers apoptosis in cancer cells. It has been designated as a fast-track drug and an orphan drug by the United States Food and Drug Administration (USFDA). Elesclomol was seen to induce oxidative stress but now it is famous for its anti-cancer properties. The anti-cancer activity based on the proliferation of cancer on the mitochondrial membrane. Elesclomol induces cuproptosis which is a process of cell death due to accumulation of copper in the mitochondrial membrane.